Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

December 31, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Dapagliflozin

Tablet oral 10 mg total daily dose once daily 102 weeks

DRUG

Metformin

Tablet oral 1500 - 2500 mg total daily dose 1-3 times a day104 weeks

DRUG

Sitagliptin

Tablet oral 100 mg total daily dose once daily rescue medication

DRUG

Placebo

Matching placebo for dapagliflozin, tablet, oral, once daily, 102 weeks

Trial Locations (21)

Unknown

Research Site, Blagoevgrad

Research Site, Sofia

Research Site, Beroun

Research Site, Brno

Research Site, Prague

Research Site, Semily

Research Site, Slaný

Research Site, Balatonfüred

Research Site, Budapest

Research Site, Csongrád

Research Site, Kecskemét

Research Site, Tát

Research Site, Elblag

Research Site, Krakow

Research Site, Torun

Research Site, Gothenburg

Research Site, Jarfalla

Research Site, Lund

Research Site, Malmo

Research Site, Stockholm

Research Site, Uppsala

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY